<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>Flmodafinil</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>Flmodafinil</h2><ul>
<li><img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSO9vNXDOROTKqOQcLgd5trt02gH-0A-o-nUQ&amp;s"/></li>
<li>Wakefulness-promoting agent</li>
<li>Developed for treatment of a variety of different medical conditions. These include chronic fatigue syndrome, idiopathic hypersomnia, narcolepsy, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease.</li>
<li>The drug has been found to act as a selective atypical dopamine reuptake inhibitor.</li>
<li>Produces wakefulness-promoting effects in animals.</li>
<li>Unlike modafinil, flmodafinil does not induce cytochrome P450 enzymes.</li>
<li>Selective dopamine reuptake inhibitor (DRI).</li>
<li>Affinity (Ki) for the DAT is 4,090 nM.</li>
<li>At the serotonin transporter (SERT), its affinity (Ki) was 48,700 nM (12-fold lower than for the DAT).</li>
<li>Negligible affinity for the sigma σ1 receptor (Ki &gt; 100,000 nM).</li>
<li>The drug has been found to block the dopamine transporter (DAT) by 83%, to a greater extent than methylphenidate without unfavorable concomitant adrenergic effects.</li>
<li>Atypical DRI similarly to modafinil.</li>
<li>Similarly to modafinil, (S)-(+)-flmodafinil and (R)-(–)-flmodafinil increase dopamine levels in the nucleus accumbens in animals. They have been found to increase dopamine levels by up to 150 to 200% of baseline at the highest assessed dose.</li>
<li>In contrast to modafinil, flmodafinil is not an inducer of the cytochrome P450 CYP3A4 or CYP3A5 enzymes.</li>
</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main></body></html>